UW-Madison spin-off organization Stemina Biomarker Discovery is attempting to create a biological method to diagnose autism by screening blood samples.
CEO Elizabeth Donley and UW-Madison professor in the Department of Animal Sciences Gabriela Cezar founded the company in 2006, according to a university release.